ClinEdge, a global pharmaceutical and site clinical trial solutions provider, has announced a dedicated offering to support clinical development efforts as study landscape shifts due to the COVID-19 crisis, the company said.
The enhanced ClinEdge product line called “Community Clinical Study Services” is a unique blend of remote, patient-centric, community based clinical trial services that streamlines the clinical trial process and connects participating sites, labs and patients through central communication, education, and training to ensure that patient visits can be conducted virtually, in person, or within the comforts of their home.
ClinEdge partners with both research sites and pharmaceutical companies to procure and conduct clinical trials, manage patient recruitment and retention campaigns, and construct and execute patient engagement strategies. The Community Clinical Study Service model plugs into ongoing or upcoming studies with a blended home health care integration that includes at-home visit completion, staffing, IP & lab shipping, handling and courier services. With telemedicine enabled remote visit assessments and implementation of our patient navigators, our technology enables patient source to be tracked seamlessly and accordingly while complying with FDA guidelines and stay at home guidelines.
ClinEdge, a portfolio company of ClinX, provides a full suite of clinical and outsourced business services to clinical research institutions, pharmaceutical companies, and CRO´s. The company includes a global site network of research clinics, marketing and creative design services, patient recruitment, and patient travel services. To learn more about ClinEdge visit www.Clin-Edge.com.